2Cohen GL.Migraine prophylactic drugs work via ion channels[J].Med Hyphotheses,2005,65(1):114-122.
3Welch KM.Contemporary concepts of migraine pathogenesis[J].Neurology,2003,61(8 suppl 4):S2-8.
4Lipton RB,Stewart WF,Diamond S,et al.Prevalence and burden of migraine in the United States:data from the American Migraine Study Ⅱ[J].Headache,2001,41(7):646-657.
5江苏新医学院.中药大辞典[M].上海：上海科技出版社,1986.739.
6黄春林.新编中药药理与临床手册[M].北京:人民卫生出版社,2007:140,651.
二级参考文献10
1Lipton RB,Diamond S,Reed M,et al.Migraine diagnosis and treatment:results from the American Migraine Study Ⅱ.Headache,2001,41:638-645.
2Silberstein SD.Practice parameter:evidence-based guidelines for migraine headache (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2000,55:754-762.
3Ferrari MD,Roon KI,Lipton RB,et al.Oral triptans (serotonin 5-HT(1B/1 D) agonists) in acute migraine treatment:a meta-analysis of 53 trials/ Lancet,2001,358:1668-1675.
4Headache Classification Subcommittee of the International Headache Society.The Internatiional Classificatiion of Headache Disorders:2nd edition.Cephalalgia,2004,24 Suppl 1:9-160.
5Lawrence EC.Diagnosis and management of migraine headaches.South Med J,2004,97:1069-1077.
6Goadsby PJ,Lipton RB,Ferrari MD.Migraine-current understanding and treatment.N Engl J Med,2002,346:257-270.
7Lipton RB,Stewart WF,Stone AM,et al.Stratified care vs step care strategies for migraine:the Disablility in Strategies of Care(DISC) Study:A randomized trial.JAMA,2000,284:2599-2605.
8Lipton RB,Bigal ME.Migraine:epidemiology,impact,and risk factors for progression.Headache,2005,45:Suppl 1:S3-S13.
9Silberstein SD,Rosenberg J.Multispecialty consensus on diagnosis and treatment of headache.Neurology,2000,54:1553.
10Snow V,Weiss K,Wall EM,et al.Pharmacologic management of acute attacks of migraine and prevention of migraine headache.Ann Intern Med,2002,137:840-849.
